h3gm is a leading Nashville-based law firm in representing companies in the life sciences and biotechnology industries. Our representation stretches back more than twenty years and includes both public and private companies throughout the United States. Recent engagements include clients in such diverse life sciences and biotechnology industries as clinical laboratories, clinical research organizations, genomics, emerging gene therapy, bioengineering, specialty pharmacy companies, institutional pharmacies, and medical device manufacturers.
Our firm is a founding member of the Tennessee Biotechnology Association, a group created to advance the common goals of Tennessee’s biotechnology community.
Our biotechnology and life sciences clients include:
- Clinical research organizations
- Divisions of a publicly traded multi-national company engaged in marketing "below threshold" drugs
- Clinical laboratories
- Medical device manufacturers
- Drug development companies
- Emerging imaging technology companies
- Life sciences software companies
Our attorneys have handled a wide variety of transactions for biotechnology and life sciences companies. Examples include:
- Public and private securities offerings and venture capital fundings of over $1 billion for a wide variety of life science companies
- Sale of numerous biotechnology and life sciences companies
- Purchase and licensing of pharmaceuticals and related intellectual property rights from international drug companies
- Sale of leading pharmaceutical distribution company for over $300 million
- Purchases and sales of clinical laboratories
- Joint venture and patent licensing transactions for drug development companies
- Over $1 billion of acquisitions and dispositions of institutional pharmacy companies
Our biotechnology and life sciences engagements include:
- Venture capital transactions
- Mergers and acquisitions
- Patent licensing
- Drug manufacturing agreements
- Negotiating contractual arrangements with international pharmaceutical companies
- Litigation and dispute resolution regarding intellectual property rights infringement
- Government regulatory advice and compliance
- Capital formation and start-up company assistance
- Strategic partnerships and joint ventures
People
- Curtis Capeling
615.251.1053 - David Cox
615.251.1081 - Mark Manner
615.251.1066
